US 9376680
Serpinc1 iRNA compositions and methods of use thereof
granted A61KA61K31/713A61P
Quick answer
US patent 9376680 (Serpinc1 iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 55
- CPC classes
- A61K, A61K31/713, A61P, A61P43/00, A61P7/04